Cargando…
Moxifloxacin in the treatment of skin and skin structure infections
Moxifloxacin is a recent addition to the fluoroquinolone class, differing from ciprofloxacin and other older agents in having much better in vitro activity against Gram-positive aerobes while retaining potent activity against Gram-negative aerobes. It is also active against the pathogens of human an...
Autor principal: | Guay, David RP |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936362/ https://www.ncbi.nlm.nih.gov/pubmed/18360653 |
Ejemplares similares
-
Moxifloxacin in Complicated Skin and Skin Structure Infections (cSSSIs): A Prospective, International, Non-Interventional, Observational Study
por: Bogner, Johannes R., et al.
Publicado: (2013) -
Role of telavancin in treatment of skin and skin structure infections
por: Bonkowski, Joseph, et al.
Publicado: (2010) -
Skin and skin structure infections: treatment with newer generation fluoroquinolones
por: Giordano, Philip, et al.
Publicado: (2007) -
Ceftaroline in complicated skin and skin-structure infections
por: Hernandez, Paul O, et al.
Publicado: (2012) -
Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
por: Leuthner, Kimberly D, et al.
Publicado: (2016)